EDAP TMS SA

FOCL ·Healthcare, Medical Devices, France
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Jun 2025 Mar 2025
Revenue $13.2M $17.8M $9.5M $14.3M
Cost of Revenue $5.9M $9.7M $4.6M $8.3M
Gross Profit $7.3M $8.1M $4.9M $6.0M
Gross Margin 55.6% 45.7% 51.1% 42.0%
Operating Expenses
Research & Development $2.3M $2.6M $2.3M $2.6M
SG&A Expense $5.5M $5.8M $3.9M $3.7M
Operating Income $-8.0M $-7.4M $-6.6M $-6.3M
Operating Margin -60.8% -41.4% -69.6% -44.2%
Interest Expense
Pretax Income $-14.4M $-8.9M $-6.3M $-7.3M
Income Tax Expense $8.0K $145.0K $14.0K $144.0K
Net Income $-14.5M $-9.1M $-6.4M $-7.4M
Net Margin -109.7% -51.0% -67.4% -52.2%
EPS (Basic) $-0.39 $-0.24 $-0.17 $-0.20
EPS (Diluted) $-0.39 $-0.24 $-0.17 $-0.20
Shares Outstanding (Basic) 37.5M 37.5M 37.4M 37.4M
Shares Outstanding (Diluted) 37.5M 37.5M 37.4M 37.4M
Dividends Per Share